Using a discrete choice experiments to explore societal preferences for valuing new drugs for rare diseases
Abstract Background Rare diseases affect few people, but collectively they affect a substantial proportion of the population. Limited treatment options and the additional challenges of securing public funding make reimbursement decision making particularly complex, mainly due to the inherent evidenc...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-12-01
|
| Serija: | Orphanet Journal of Rare Diseases |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s13023-025-04141-0 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|